| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
|
J Clin Oncol
|
2010
|
14.41
|
|
2
|
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
|
Arch Pathol Lab Med
|
2010
|
4.38
|
|
3
|
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
|
Arch Pathol Lab Med
|
2010
|
2.72
|
|
4
|
The role of mutators in the emergence of antibiotic-resistant bacteria.
|
Drug Resist Updat
|
2003
|
2.07
|
|
5
|
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
|
Lancet Infect Dis
|
2008
|
1.96
|
|
6
|
The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis.
|
Clin Gastroenterol Hepatol
|
2007
|
1.83
|
|
7
|
External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme.
|
Am J Clin Pathol
|
2009
|
1.57
|
|
8
|
Recent advances in operant conditioning technology: a versatile and affordable computerized touchscreen system.
|
Behav Res Methods Instrum Comput
|
2004
|
1.30
|
|
9
|
Digital slides: present status of a tool for consultation, teaching, and quality control in pathology.
|
Pathol Res Pract
|
2009
|
1.29
|
|
10
|
Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus.
|
J Antimicrob Chemother
|
2008
|
1.25
|
|
11
|
Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.
|
Am J Clin Pathol
|
2009
|
1.23
|
|
12
|
Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus.
|
J Antimicrob Chemother
|
2004
|
1.22
|
|
13
|
Anti-staphylococcal activity and mode of action of clofazimine.
|
J Antimicrob Chemother
|
2004
|
1.17
|
|
14
|
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
|
J Antimicrob Chemother
|
2010
|
1.04
|
|
15
|
Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (SP2): findings of the UK National External Quality Assessment Scheme for Immunocytochemistry and FISH highlight the need for correct validation of antibodies on introduction to the laboratory.
|
Am J Clin Pathol
|
2008
|
0.99
|
|
16
|
Biological properties of novel antistaphylococcal quinoline-indole agents.
|
Antimicrob Agents Chemother
|
2003
|
0.97
|
|
17
|
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.
|
Appl Immunohistochem Mol Morphol
|
2015
|
0.97
|
|
18
|
Ectopic prostatic tissue in the uterine cervix and vagina: report of a series with a detailed immunohistochemical analysis.
|
Am J Surg Pathol
|
2006
|
0.95
|
|
19
|
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.
|
J Antimicrob Chemother
|
2009
|
0.95
|
|
20
|
Spitz nevus with Homer-Wright rosette-like structures.
|
Am J Dermatopathol
|
2012
|
0.88
|
|
21
|
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.
|
J Exp Clin Cancer Res
|
2012
|
0.88
|
|
22
|
Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase.
|
Antimicrob Agents Chemother
|
2010
|
0.87
|
|
23
|
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
|
J Med Chem
|
2009
|
0.83
|
|
24
|
Zeocin resistance suppresses mutation in hypermutable Escherichia coli.
|
Microbiology
|
2003
|
0.83
|
|
25
|
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme.
|
J Clin Pathol
|
2006
|
0.82
|
|
26
|
A UK NEQAS ISH multicenter ring study using the Ventana HER2 dual-color ISH assay.
|
Am J Clin Pathol
|
2011
|
0.82
|
|
27
|
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.82
|
|
28
|
Rapid multiplexed flow cytometric assay for botulinum neurotoxin detection using an automated fluidic microbead-trapping flow cell for enhanced sensitivity.
|
Anal Chem
|
2009
|
0.81
|
|
29
|
Reprocessing and sterilization of single-use electrophysiological catheters: removal of organic carbon and protein surface residues.
|
J AOAC Int
|
2009
|
0.81
|
|
30
|
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma.
|
J Cancer Res Clin Oncol
|
2013
|
0.81
|
|
31
|
2-Aminotetralones: novel inhibitors of MurA and MurZ.
|
Bioorg Med Chem Lett
|
2008
|
0.80
|
|
32
|
Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH.
|
Am J Clin Pathol
|
2009
|
0.80
|
|
33
|
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH.
|
Histopathology
|
2010
|
0.79
|
|
34
|
Variation in rates of oestrogen receptor positivity in breast cancer again.
|
BMJ
|
2002
|
0.79
|
|
35
|
Information technology and hospice palliative care: social, cultural, ethical and technical implications in a rural setting.
|
Inform Health Soc Care
|
2011
|
0.78
|
|
36
|
The need for a quality control of the whole process of immunohistochemistry human epidermal growth factor receptor 2/neu determination: a United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers pilot experience.
|
J Clin Oncol
|
2007
|
0.78
|
|
37
|
Suitability of infiltrative lobular breast carcinoma for anti-human epidermal growth factor receptor 2 treatment after the ASCO/CAP and 2009 St Gallen International Expert Consensus meeting.
|
Histopathology
|
2010
|
0.78
|
|
38
|
Multi-gigabit/s underwater optical communication link using orbital angular momentum multiplexing.
|
Opt Express
|
2016
|
0.78
|
|
39
|
8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.
|
J Med Chem
|
2009
|
0.78
|
|
40
|
Can the intestinal dysmotility of critical illness be differentiated from postoperative ileus?
|
Curr Gastroenterol Rep
|
2011
|
0.78
|
|
41
|
Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligands.
|
Bioorg Med Chem Lett
|
2002
|
0.77
|
|
42
|
Synthesis and antimicrobial activity of novel substituted ethyl 2-(quinolin-4-yl)-propanoates.
|
Molecules
|
2013
|
0.77
|
|
43
|
Prognostic factors in ovarian adult granulosa cell tumour.
|
J Clin Pathol
|
2008
|
0.76
|
|
44
|
Comparison of in vivo clinical performance and shaft temperature and in vitro tissue temperature and transection times between new and reprocessed harmonic scalpels.
|
Surg Laparosc Endosc Percutan Tech
|
2010
|
0.76
|
|
45
|
Evolution of extended-spectrum beta-lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator.
|
J Antimicrob Chemother
|
2006
|
0.75
|
|
46
|
Cell line standards to reduce HER-2/neu assay variation and the potential of automated image analysis to provide more accurate cut points for predicting clinical response to trastuzumab.
|
Am J Clin Pathol
|
2005
|
0.75
|
|
47
|
Not All Abdomens Are the Same: A Comparison of Damage Control Surgery for Intra-abdominal Sepsis versus Trauma.
|
Am Surg
|
2016
|
0.75
|
|
48
|
Nondestructive quality control of HER2 control cell line sections: the use of interferometry for measuring section thickness and implications for HER2 interpretation on breast tissue.
|
Appl Immunohistochem Mol Morphol
|
2009
|
0.75
|
|
49
|
Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
|
Appl Immunohistochem Mol Morphol
|
2015
|
0.75
|
|
50
|
Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-releasing factor (CRF) receptor ligands.
|
Bioorg Med Chem
|
2003
|
0.75
|
|
51
|
Concentric vortex beam amplification: experiment and simulation.
|
Opt Express
|
2016
|
0.75
|
|
52
|
Evaluation of target efficiencies for solid-liquid separation steps in biofuels production.
|
Appl Biochem Biotechnol
|
2010
|
0.75
|
|
53
|
Reprocessed arthroscopic shavers: evaluation of sharpness and function in a cadaver model.
|
Orthopedics
|
2014
|
0.75
|
|
54
|
Quality: The perspective that counts most.
|
Health Serv J
|
2012
|
0.75
|
|
55
|
Lasing characteristics of Ho:YAG single crystal fiber.
|
Opt Express
|
2016
|
0.75
|
|
56
|
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.75
|
|
57
|
Heroin-Related Compartment Syndrome: An Increasing Problem for Acute Care Surgeons.
|
Am Surg
|
2017
|
0.75
|
|
58
|
Ecological Assessment of Substance-abuse Experiences (EASE): findings from a new instrument development pilot study.
|
Addict Behav
|
2005
|
0.75
|
|
59
|
Arylamidrazones as novel corticotropin releasing factor receptor antagonists.
|
J Med Chem
|
2002
|
0.75
|
|
60
|
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|
|
61
|
Comparison of performance characteristics between new and reprocessed electrophysiology catheters.
|
J Interv Card Electrophysiol
|
2007
|
0.75
|
|
62
|
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.
|
J Cutan Pathol
|
2009
|
0.75
|
|
63
|
Propagation of modulated optical beams carrying orbital angular momentum in turbid water.
|
Appl Opt
|
2016
|
0.75
|
|
64
|
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|